Gain Therapeutics Inc.
(GANX)
undefined
undefined%
At close: undefined
1.50
-7.98%
Pre-market Dec 16, 2024, 04:03 AM EST
Ratios (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -0.48 | -0.53 | -0.99 | -9.29 | -15.16 | -14.84 |
| PS Ratio | 192.77 | 66.37 | 83.64 | 1151.42 | 805.16 | 796.18 |
| PB Ratio | 0.85 | 0.49 | 0.40 | 5.36 | -73.92 | -17.26 |
| P/FCF Ratio | -0.56 | -0.63 | -1.11 | -10.20 | -17.67 | -21.81 |
| P/OCF Ratio | -0.56 | -0.63 | -1.12 | -10.26 | -17.80 | -22.04 |
| OCF/S Ratio | -85.47 | -26.22 | -18.74 | -28.05 | -11.31 | -9.03 |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.03 | 0.00 | -0.26 |
| Quick Ratio | 0.90 | 1.28 | 3.69 | 0.90 | 0.11 | 0.23 |
| Current Ratio | 0.90 | 1.28 | 3.69 | 1.06 | 0.12 | 0.23 |
| Asset Turnover | 0.00 | 0.01 | 0.00 | 0.00 | 0.06 | 0.03 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -25.56 | 0.00 |
| Return on Equity (ROE) | -177.03% | -93.17% | -39.90% | -57.69% | 487.59% | 116.26% |
| Return on Assets (ROA) | -119.66% | -72.99% | -35.63% | -37.25% | -332.20% | -136.21% |
| Return on Capital (ROIC) | -162.91% | -89.00% | -37.95% | -46.46% | 959.98% | -366.15% |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Gross Profit Margin | -11.42% | 13.55% | -1060.53% | -1930.61% | 25.00% | 25.00% |
| Net Profit Margin | -10088.58% | -3138.78% | -2104.71% | -3096.92% | -1327.72% | -1341.09% |